COGSCREEN, LLC
ST. PETERSBURG, FLORIDA

Dr. Gary Kay is the developer and publisher of CogScreen. From 1985 to 1998, Dr. Kay served as the Director of the Neuropsychology Division of the Georgetown University School of Medicine's Department of Neurology. In this capacity he was actively engaged in teaching, clinical service, and research. His research activities focused on development of computerized methods for assessing higher cortical functions, and investigation of the neuropsychological sequelae of HIV infection, head injury, fibromyalgia, diabetes, eosinophilia myalgia syndrome, alcoholism, and normal aging. Dr. Kay has served as the Principal Investigator on single and multi-center clinical drug trials investigating the effects of medications on cognition, mood, and psychomotor performance. Recent studies have investigated changes in cognition associated with sedating antihistamines, hormone replacement therapy, and nutritional supplements. In 1998 Dr. Kay established the Washington Neuropsychological Institute, a firm that consults and carries out contract research and educational programs for federal agencies (e.g., Federal Aviation Administration, Social Security Administration) and industry. CogScreen- (CogScreen) is a computer-administered and scored cognitive-screening instrument designed to rapidly assess deficits or changes in attention, immediate- and short-term memory, visual perceptual functions, sequencing functions, logical problem solving, calculation skills, reaction time, simultaneous information processing abilities, and executive functions. CogScreen- was initially designed to meet the Federal Aviation Administration's (FAA) need for an instrument that could detect subtle changes in cognitive functioning: "changes which left unnoticed may result in poor pilot judgment or slow reaction time in critical operational situations" (Engelberg, Gibbons, & Doege, 1986, p. lS89). One version, CogScreen-AE, meets the FAA's requirement for a sensitive and specific neuro-cognitive test battery for use in the medical re certification evaluation of pilots with known or suspected neurological and/or psychiatric conditions CogScreen-AE is not a test of aviation knowledge or flying skills, but rather a measure of the underlying perceptual cognitive, and information processing abilities associated with flying (Imhoff & Levine, 1986) CogScreen- consists of a series of computerized cognitive tasks, each self-contained and presented with instructions and a practice segment. The subtests are listed and described below. CogScreen has been used to detect the impact of a variety of medications on Brain Function.